Other
Protocol based
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Terminated(1)
Detailed Status
Enrolling by invitation2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
enrolling_by_invitation267%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
enrolling_by_invitationnot_applicable
Thirst Translation and RCT
NCT07157917
enrolling_by_invitationnot_applicable
Application of a Comprehensive Protocol Aimed at Reducing the Risk of Complications After Surgery for Sarcoma. Interventions Before, During and After Surgery for Known and Presumed Risk Factors Compared to Standard of Care in a Total of 300 Patients.
NCT06968884
terminatednot_applicable
Comparison of the Incidence of Inadequate Epidural Analgesia Between Protocol Based and Current Practice
NCT04111406
Clinical Trials (3)
Showing 3 of 3 trials
NCT07157917Not Applicable
Thirst Translation and RCT
NCT06968884Not Applicable
Application of a Comprehensive Protocol Aimed at Reducing the Risk of Complications After Surgery for Sarcoma. Interventions Before, During and After Surgery for Known and Presumed Risk Factors Compared to Standard of Care in a Total of 300 Patients.
NCT04111406Not Applicable
Comparison of the Incidence of Inadequate Epidural Analgesia Between Protocol Based and Current Practice
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3